Dovetail Genomics Expands European Operations with CNAG Certification

Dovetail Genomics, a prominent player in Hi-C genomic services, has recently announced a significant milestone in enhancing genomic research accessibility across Europe. The Centro Nacional de Análisis Genómico (CNAG), located in Barcelona, Spain, has become the first-ever Certified Service Provider (CSP) in Europe under Dovetail’s esteemed certification program. This collaboration aims to provide researchers with unparalleled access to high-quality genomic services that are pivotal for various scientific and clinical applications.

A Commitment to Quality and Accessibility

The Certified Service Provider initiative reflects Dovetail Genomics' ongoing commitment to advancing the quality and accessibility of genomic data. As part of this program, certified laboratories like CNAG must meet stringent standards regarding data quality and proficiency, ensuring that researchers receive reliable data essential for critical genomic studies. This certification assures clients of the data’s quality, which is vital for producing haplotype-resolved genome assemblies, understanding the complexities of three-dimensional genome structures, and identifying genetic variants associated with various diseases.

Miles Collier, Director of Sales for the EMEA region at Dovetail Genomics, expressed enthusiasm about the partnership, stating, "We look for excellence and reliability in our partners, and with the Centro Nacional de Análisis Genómico, we have found this in abundance. We are delighted that they have chosen to become the first Certified Service Provider for genomic analysis in Europe and look forward to continuing to work with the lab into the future."

Innovating Genomic Research in Spain

CNAG has a history of pioneering genomic research and plays a crucial role in forwarding the field in Spain and beyond. The state-of-the-art lab, known for its advanced sequencing techniques, now enhances its capabilities through Dovetail's cutting-edge Omni-C® technology, which further improves the services provided to both academic and clinical researchers. By joining Dovetail’s CSP program, CNAG solidifies its position as a leader in genomic services, enabling better research opportunities for biopharma firms and contract research organizations (CROs) as well.

Marta Gut, the Head of CNAG’s Sequencing Unit, commented on this achievement: "We are proud to join the Dovetail Certified Service Provider program, highlighting our commitment to quality and our expertise in providing Hi-C technology to the international research community. Our certification underscores our dedication to delivering reliable and high-quality results that drive scientific discovery."

Driving Scientific Discovery

The certification of CNAG under the Dovetail® Omni-C® program empowers the organization to offer advanced genomic services vital for research into complex genomic structures. CNAG's status as a certified service provider not only enhances its support for the scientific community but also underscores Dovetail Genomics’ mission to expand the global reach of its innovative Hi-C technologies.

For those interested in exploring certification opportunities or learning more about Dovetail Genomics’ expansive services, more information is available on their official website: www.dovetailgenomics.com.

About Dovetail Genomics

Dovetail Genomics utilizes linked-read technology to unlock genomic access at an unprecedented level. By providing insights into epigenetics, genetic variation, and genome assembly, they address complex research challenges spanning chromatin structure analysis, genetic variation detection, and de novo chromosome assembly. Their services are designed to support researchers in diverse areas, from population genomics to clinical drug discovery.

About CNAG

Founded in 2009, the Centro Nacional de Análisis Genómico (CNAG) serves as a pivotal genomic research center, playing a vital role in enhancing the scientific infrastructure in Catalonia and throughout Spain. CNAG focuses on genome projects aimed at improving public health and ensuring competitive advancements in biomedicine and agronomy. With advanced technologies, CNAG conducts over a thousand research projects annually, supporting a vast network of both national and international research institutions. For more information about CNAG, visit www.cnag.eu.